Equities

Quanterix Corp

QTRX:NMQ

Quanterix Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)11.72
  • Today's Change0.70 / 6.35%
  • Shares traded417.58k
  • 1 Year change-50.32%
  • Beta1.3041
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

  • Revenue in USD (TTM)129.33m
  • Net income in USD-39.71m
  • Incorporated2007
  • Employees441.00
  • Location
    Quanterix Corp900 Middlesex TurnpikeBILLERICA 01821United StatesUSA
  • Phone+1 (617) 301-9400
  • Fax+1 (302) 655-5049
  • Websitehttps://www.quanterix.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Clearpoint Neuro Inc30.43m-18.15m302.33m107.00--10.43--9.94-0.6912-0.69121.161.050.72421.509.66284,383.20-43.19-34.75-51.20-39.6760.3864.75-59.64-76.913.61--0.00--16.5626.64-34.40--75.30--
Delcath Systems Inc22.64m-34.12m307.91m76.00--31.48--13.60-1.36-1.360.83430.30590.57140.90946.34297,947.40-86.11-116.57-156.17-243.2181.3171.02-150.70-1,235.371.03-172.600.1892---24.05-9.53-30.60---5.26--
Cerus Corp197.91m-19.73m308.29m288.00--5.76--1.56-0.1076-0.10761.080.28821.001.977.88687,194.40-10.01-25.99-15.26-40.6260.5261.90-10.00-35.811.92-1.190.6057---0.806119.6912.37--32.07--
CVRx Inc47.26m-58.48m328.04m200.00--5.02--6.94-2.71-2.712.192.690.40380.6576.14236,275.00-49.96---54.21--84.16---123.75--10.23-17.040.4302--74.89--0.5528------
Nano-X Imaging Ltd10.13m-57.47m344.55m164.00--1.97--34.02-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
MaxCyte Inc45.60m-35.74m368.13m143.00--1.72--8.07-0.3420-0.34200.43682.030.1770.55767.17318,878.30-13.87-13.18-14.86-14.3385.9888.79-78.37-62.969.22--0.00---6.7219.89-60.89--39.13--
ZimVie Inc451.30m-47.73m372.31m2.60k--0.9152--0.825-1.77-13.1616.6014.740.3941.144.04173,575.00-4.17---4.81--63.1865.51-10.58-8.731.38-0.62640.3514---1.26-16.08-19.50---23.70--
Tactile Systems Technology Inc285.05m15.45m373.39m992.0024.201.8016.861.310.6430.64311.918.660.98126.206.80287,349.805.320.90156.201.0951.4449.105.420.83093.80--0.11460.0011.2013.81259.6033.91-23.62--
Alpha Teknova Inc36.35m-31.68m412.57m210.00--4.73--11.35-0.7366-0.73660.8341.640.27703.127.44173,081.00-24.14---25.92--17.71---87.17--3.94-75.860.133---11.43--22.52------
Quanterix Corp129.33m-39.71m422.94m441.00--1.26--3.27-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Semler Scientific Inc58.94m15.91m430.67m92.0028.924.9426.027.312.052.057.5811.990.686817.209.33640,619.6018.5438.8320.3744.4188.0590.2227.0032.583.09--0.00--20.2825.9843.6932.64-0.3821--
Pacific Biosciences of California Inc173.15m-394.24m468.75m796.00--1.04--2.71-1.46-1.460.641.650.10341.975.78217,521.40-23.55-16.19-25.40-17.8123.8137.35-227.69-136.218.64-21.870.6634--56.2920.592.39--36.68--
Treace Medical Concepts Inc202.86m-61.52m497.13m516.00--4.74--2.45-0.9924-0.99243.271.680.89511.088.25393,141.50-27.15---32.22--80.61---30.33--2.98--0.3366--31.92---15.68------
SI-Bone Inc157.04m-37.40m509.55m344.00--3.08--3.24-0.9108-0.91083.823.950.68591.467.00456,497.10-16.34-27.88-18.08-30.9477.7085.03-23.82-51.097.22--0.1799--30.5220.1929.25--52.62--
Mesa Laboratories Inc228.38m-245.65m535.48m736.00--3.31--2.34-45.57-45.5742.1329.790.41862.745.96310,298.90-45.02-9.20-54.70-9.8862.4760.60-107.56-28.330.51061.350.5594---1.3215.95-27,438.28--15.260.00
Simulations Plus Inc70.01m9.95m553.45m243.0056.353.0335.437.910.48940.48943.459.100.3659--5.55288,119.305.206.105.556.4561.6374.0114.2218.97----0.0045.6417.5215.56-0.07033.0117.070.00
Data as of Nov 21 2024. Currency figures normalised to Quanterix Corp's reporting currency: US Dollar USD

Institutional shareholders

46.79%Per cent of shares held by top holders
HolderShares% Held
AllianceBernstein LPas of 30 Sep 20243.27m8.51%
BlackRock Fund Advisorsas of 30 Sep 20242.80m7.29%
Portolan Capital Management LLCas of 30 Sep 20242.52m6.57%
The Vanguard Group, Inc.as of 30 Sep 20242.14m5.57%
Millennium Management LLCas of 30 Sep 20242.06m5.37%
Threadneedle Asset Management Ltd.as of 30 Sep 20241.50m3.92%
Granahan Investment Management, LLCas of 30 Sep 20241.10m2.87%
Easterly Investment Partners LLCas of 30 Sep 2024876.13k2.28%
Geode Capital Management LLCas of 30 Sep 2024858.67k2.24%
SSgA Funds Management, Inc.as of 30 Sep 2024836.44k2.18%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.